Sciensus delivered Cosentyx pens to Belfast trust patients at home
- Belfast Health and Social Care Trust
- Northern Ireland
- Direct
- 9 October 2025 to 30 September 2027
Sciensus Pharma Services Limited supplied Belfast Health and Social Care Trust with secukinumab (Cosentyx) 300 mg pre-filled pens for patients treated at home.
The homecare service covered secure storage, logistics and delivery of the biologic medicine to each patient, so treatment could carry on outside a clinical setting.
The trust awarded the £3.5m contract directly to run for two years from October 2025. It ended early, in April 2026.
Contract ends September 2027
- What
- Homecare medicines services
- Supplier
- Sciensus Pharma Services Limited
- Value
- £3.5m
- How it was bought
- Direct
- Dates and next
- Oct 2025 to Sep 2027